Current and emerging strategies for the treatment and management of systemic lupus erythematosus based on molecular signatures of acute and chronic inflammation

References

• DasUNClinical laboratory tools to diagnose inflammationAdv Clin Chem200641189229
   Web of Science ®Google Scholar
• SerhanCNLipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolutionProstaglandins Leukot Essent Fatty Acids2005733–414116216005201
   PubMed Web of Science ®Google Scholar
• ClariaJSerhanCNAspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactionsProc Natl Acad Sci U S A19959221947594797568157
   PubMed Web of Science ®Google Scholar
• DasUNCOX-2 inhibitors and metabolism of essential fatty acidsMed Sci Monit2005117RA23323715990700
   PubMed Web of Science ®Google Scholar
• SerhanCNHongSGronertKResolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signalsJ Exp Med20021961025103712391014
   PubMed Web of Science ®Google Scholar
• DasUNCan COX-2 inhibitors-induced increase in cardiovascular disease risk be modified by essential fatty acidsJ Assoc Physicians India20055362362716190133
   PubMedGoogle Scholar
• ChiangNAritaMSerhanCNAnti-inflammatory circuitry: lipoxin, aspirin-triggered lipoxins and their receptor ALXProstaglandins Leukot Essent Fatty Acids20057316317716125378
   PubMed Web of Science ®Google Scholar
• LevyBDClishCBSchmidtBGronertKSerhanCNLipid mediator class switching during acute inflammation: signals in resolutionNat Immunol20012761261911429545
   PubMed Web of Science ®Google Scholar
• SerhanCNMaddoxJFPetasisNADesign of lipoxin A4 stable analogs that block transmigration and adhesion of human neutrophilsBiochemistry1995344414609146157578068
   PubMed Web of Science ®Google Scholar
• KerrDJDunnJALangmanMJRofecoxib and cardiovascular adverse events in adjuvant treatment of colorectal cancerN Engl J Med2007357436036917652651
   PubMed Web of Science ®Google Scholar
• XiaoGTasiA-LPalmerGBoyarWCMarshallPJKulmaczRJAnalysis of hydroperoxide-induced tyrosyl radicals and lipoxygenase activity in aspirin-treated human prostaglandin H synthase-2Biochemistry1997367183618459048568
   PubMed Web of Science ®Google Scholar
• ZordokyBNEl-KadiAOEffect of cytochrome P450 polymorphism on arachidonic acid metabolism and their impact on cardiovascular diseasesPharmacol Ther2010125344646320093140
   PubMed Web of Science ®Google Scholar
• NithipatikomKGrossGJReview article: epoxyeicosatrienoic acids: novel mediators of cardioprotectionJ Cardiovasc Pharmacol Ther201015211211920200327
   PubMed Web of Science ®Google Scholar
• CampbellWBFlemingIEpoxyeicosatrienoic acids and endothelium-dependent responsesPflugers Arch2010459688189520224870
   PubMed Web of Science ®Google Scholar
• ArnoldCKonkelAFischerRSchunckWHCytochrome P450-dependent metabolism of omega-6 and omega-3 long-chain polyunsaturated fatty acidsPharmacol Rep201062353654720631419
   PubMed Web of Science ®Google Scholar
• KroetzDLZeldinDCCytochrome P450 pathways of arachidonic acid metabolismCurr Opin Lipidol200213327328312045397
   PubMed Web of Science ®Google Scholar
• GaoLYinHMilneGLPorterNAMorrowJDFormation of F-ring isoprostane-like compounds (F3-isoprostanes) in vivo from eicosapentaenoic acidJ Biol Chem200628120140921409916569632
   PubMed Web of Science ®Google Scholar
• GrimmingerFMayserPPapavassilisCA double-blind, randomized, placebo-controlled trial of n-3 fatty acid based lipid infusion in acute, extended guttate psoriasis. Rapid improvement of clinical manifestations and changes in neutrophil leukotriene profileClin Investig1993718634643
   Google Scholar
• SerhanCNClishCBBrannonJColganSPChiangNGronertKNovel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processingJ Exp Med200019281197120411034610
   PubMed Web of Science ®Google Scholar
• SerhanCNClishCBBrannonJColganSPGronertKChiangNAnti-microinflammatory lipid signals generated from dietary N-3 fatty acids via cyclooxygenase-2 and transcellular processing: a novel mechanism for NSAID and N-3 PUFA therapeutic actionsJ Physiol Pharmacol2000514 Pt 164365411192938
   PubMed Web of Science ®Google Scholar
• MarcheselliVLHongSLukiwWJNovel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expressionJ Biol Chem200327844438074381712923200
   PubMed Web of Science ®Google Scholar
• HongSGronertKDevchandPRMoussignacRLSerhanCNNovel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in antiinflammationJ Biol Chem200327817146771468712590139
   PubMed Web of Science ®Google Scholar
• KatohTLakkisFGMakitaNBadrKFCo-regulated expression of glomerular 12/15-lipoxygenase and interleukin-4 mRNAs in rat nephrotoxic nephritisKidney Int19944623413497967345
   PubMed Web of Science ®Google Scholar
• NassarGMBadrKFRole of leukotrienes and lipoxygenases in glomerular injuryMiner Electrolyte Metab1995214–52622707565475
   PubMedGoogle Scholar
• PapayianniASerhanCNPhillipsMLRennkeHGBradyHRTranscellular biosynthesis of lipoxin A4 during adhesion of platelets and neutrophils in experimental immune complexglomerulonephritis Kidney Int199547512951302
   Web of Science ®Google Scholar
• O’MearaYMBradyHRLipoxins, leukocyte recruitment and the resolution phase of acute glomerulonephritisKidney Int Suppl199758S56619067945
   PubMed Web of Science ®Google Scholar
• WuSHLiaoPYYinPLZhangYMDongLElevated expressions of 15-lipoxygenase and lipoxin A4 in children with acute poststreptococcal glomerulonephritisAm J Pathol2009174111512219095947
   PubMed Web of Science ®Google Scholar
• LattinJESchroderKSuAIExpression analysis of G protein-coupled receptors in mouse macrophagesImmunome Res20084518442421
   PubMedGoogle Scholar
• MilliganGStoddartLABrownAJG protein-coupled receptors for free fatty acidsCell Signal20061891360136516716567
   PubMed Web of Science ®Google Scholar
• OhDYTalukdarSBaeEJGPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effectsCell2010142568769820813258
   PubMed Web of Science ®Google Scholar
• BaughJADonnellySCMacrophage migration inhibitory factor: a neuroendocrine modulator of chronic inflammationJ Endocrinol20031791152314529561
   PubMed Web of Science ®Google Scholar
• DasUNCan critical illness and sepsis be predicted or prognosticatedAdv Sepsis200655259
   Google Scholar
• GandoSSawamuraAHayakawaMHoshinoHKubotaNNishihiraJHigh macrophage migration inhibitory factor levels in disseminated intravascular coagulation patients with systemic inflammationInflammation2007303–411812417534704
   PubMed Web of Science ®Google Scholar
• ChuangCCWangSTChenWCChenCCHorLIChuangAYIncreases in serum macrophage migration inhibitory factor in patients with severe sepsis predict early mortalityShock200727550350617438455
   PubMed Web of Science ®Google Scholar
• HoiAYHickeyMJHallPMacrophage migration inhibitory factor deficiency attenuates macrophage recruitment, glomerulonephritis, and lethality in MRL/lpr miceJ Immunol200617785687569617015758
   PubMed Web of Science ®Google Scholar
• MizueYNishihiraJMiyazakiTQuantitation of macrophage migration inhibitory factor (MIF) using the one-step sandwich enzyme immunosorbent assay: elevated serum MIF concentrations in patients with autoimmune diseases and identification of MIF in erythrocytesInt J Mol Med20005439740310719057
   PubMed Web of Science ®Google Scholar
• DasUNInsulin in the critically ill with focus on cytokines, reactive oxygen species, HLA-DR expressionJ Assoc Physicians India200755Suppl566517927013
   PubMedGoogle Scholar
• BozzaFAGomesRNJapiassúAMMacrophage migration inhibitory factor levels correlate with fatal outcome in sepsisShock200422430931315377884
   PubMed Web of Science ®Google Scholar
• DasUNCur rent advances in sepsis and septic shock with particular emphasis on the role of insulinMed Sci Monit200398RA18119212942044
   PubMedGoogle Scholar
• LehmannLENovenderUSchroederSPlasma levels of macrophage migration inhibitory factor are elevated in patients with severe sepsisIntensive Care Med20012781412141511511957
   PubMed Web of Science ®Google Scholar
• BozzaMSatoskarARLinGTargeted disruption of migration inhibitory factor gene reveals its critical role in sepsisJ Exp Med199918923413469892616
   PubMed Web of Science ®Google Scholar
• RovenskyJSvejcarJPekarekJZitnanDHajzokOCebecauerLCorrelation between the results of the migration inhibitory factor production test with DNA and the severity of the disease in the systemic lupus erythematosus patientsZ Immunitatsforsch Exp Klin Immunol197515012430127462
   PubMedGoogle Scholar
• ChenWYLiGRFangFThe expression of migration inhibitory factor in peripheral blood mononuclear cell and its correlation with disease activity in systemic lupus erythematosusZhonghua Nei Ke Za Zhi200443857257515355659
   PubMedGoogle Scholar
• AyoubSHickeyMJMorandEFMechanisms of disease: macrophage migration inhibitory factor in SLE, RA and atherosclerosisNature Clin Pract Rheumatol200849810518235539
   PubMedGoogle Scholar
• OtukeshHChalianMHoseiniRUrine macrophage migration inhibitory factor in pediatric systemic lupus erythematosusClin Rheumatol200726122105210717479310
   PubMed Web of Science ®Google Scholar
• FooteABrigantiEMKipenYSantosLLeechMMorandEFMacrophage migration inhibitory factor in systemic lupus erythematosusJ Rheumatol200431226827314760795
   PubMed Web of Science ®Google Scholar
• UrbonaviciuteVFürnrohrBGMeisterSInduction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLEJ Exp Med2008205133007301819064698
   PubMed Web of Science ®Google Scholar
• YinKGribbinEWangHInterferon-gamma inhibition attenuates lethality after cecal ligation and puncture in rats: implication of high mobility group box-1Shock200524439640116205327
   PubMed Web of Science ®Google Scholar
• AyerLMRubinRLDixonGHFritzlerMJAntibodies to HMG proteins in patients with drug-induced autoimmunityArthritis Rheum1994371981037907477
   PubMed Web of Science ®Google Scholar
• PopovicKEkMEspinosaAIncreased expression of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in skin lesions of patients with lupus erythematosusArthritis Rheum200552113639364516255056
   PubMed Web of Science ®Google Scholar
• BarkauskaiteVEkMPopovicKHarrisHEWahren-HerleniusMNybergFTranslocation of the novel cytokine HMGB1 to the cytoplasm and extracellular space coincides with the peak of clinical activity in experimentally UV-induced lesions of cutaneous lupus erythematosusLupus2007161079480217895302
   PubMed Web of Science ®Google Scholar
• DasUNInteraction(s) between essential fatty acids, eicosanoids, cytokines, growth factors and free radicals: relevance to new therapeutic strategies in rheumatoid arthritis and other collagen vascular diseasesProstaglandins Leukot Essent Fatty Acids19914442012101726126
   PubMed Web of Science ®Google Scholar
• RobakESysa-JeorzejewskaADziankowskaBTorzeckaDChojnowskiKRobakTAssociation of interferon gamma, tumor necrosis factor alpha and interleukin-6 serum levels with systemic lupus erythematosus activityArch Immunol Ther Exp (Warsz)19984663753809883317
   PubMedGoogle Scholar
• TucciMCalvaniNRichardsHBQuatraroCQSilvestrisFThe interplay of chemokines and dendritic cells in the pathogenesis of lupus nephritisAnn N Y Acad Sci2005105142143216126984
   PubMed Web of Science ®Google Scholar
• FalkRJJennetteJCAnti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritisN Engl J Med198831825165116572453802
   PubMed Web of Science ®Google Scholar
• ShenJYChenSLWuYXPulmonary hypertension in systemic lupus erythematosusRheumatol Int199918414715110220835
   PubMed Web of Science ®Google Scholar
• WillekePSchluterBSchotteHIncreased frequency of GM-CSF secreting PBMC in patients with active systemic lupus erythematosus can be reduced by immunoadsorptionLupus200413425726215176662
   PubMed Web of Science ®Google Scholar
• WilliamsRCJrHarmonMEBurlingameRDu ClosTWStudies of serum C-reactive protein in systemic lupus erythematosusJ Rheumatol200532345446115742436
   PubMed Web of Science ®Google Scholar
• LindseyNJHendersonFIMaliaRMilford-WardMAGreavesMHughesPInhibition of prostacyclin release by endothelial binding anticardiolipin antibodies in thrombosis-prone patients with systemic lupus erythematosus and the antiphospholipid syndromeBr J Rheumatol199433120268162452
   PubMedGoogle Scholar
• DasUNBeneficial action(s) of eicosapentaenoic acid/docosahexaenoic acid and nitric oxide in systemic lupus erythematosusMed Sci Res199523723726
   Google Scholar
• MohanIKDasUNOxidant stress, anti-oxidants and essential fatty acids in systemic lupus erythematosusProstaglandins Leukot Essent Fatty Acids19975631931989089797
   PubMed Web of Science ®Google Scholar
• ZamoraMRO’BrienRFRutherfordRFWeilJVSerum endothelin-1 concentrations and cold provocation in primary Raynaud’s phenomenonLancet19903368724114411471978025
   PubMed Web of Science ®Google Scholar
• ReimannJDiamantsteinTInterleukin-2 allows in vivo induction of anti-erythrocyte autoantibody production in nude mice associated with the injection of rat erythrocytesClin Exp Immunol19814336416446974628
   PubMed Web of Science ®Google Scholar
• RediniFGaleraPMauvielALoyauGPujolJPTransforming growth factor-beta stimulates collagen and glycosaminoglycan biosynthesis in cultured rabbit articular chondrocytesFEBS Lett198823411721763164687
   PubMed Web of Science ®Google Scholar
• FalangaVJulienJMObservations in the potential role of transforming growth factor-beta in cutaneous fibrosis. Systematic sclerosisAnn N Y Acad Sci19905931611712165374
   PubMed Web of Science ®Google Scholar
• WongCKHoCYLiEKLamCWElevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosusLupus20009858959311035433
   PubMed Web of Science ®Google Scholar
• HorwitzDAGrayJDBehrendsenSCDecreased production of interleukin-12 and other Th1 type cytokines in patients with recent onset systemic lupus erythematosusArthritis Rheum19984158388449588735
   PubMed Web of Science ®Google Scholar
• TakahashiSFossatiLIwamotoMImbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL miceJ Clin Invest1996977159716048601623
   PubMed Web of Science ®Google Scholar
• PengSLSzaboSJGlimcherLHT-bet regulates IgG class switching and pathogenic autoantibody productionProc Natl Acad Sci U S A20029985545555011960012
   PubMed Web of Science ®Google Scholar
• AkahoshiMNakashimaHTanakaYTh1/Th2 balance of peripheral T helper cells in systemic lupus erythematosusArthritis Rheum19994281644164810446863
   PubMed Web of Science ®Google Scholar
• ChanRWTamLSLiEKInflammatory cytokine gene expression in the urinary sediment of patients with lupus nephritisArthritis Rheum20034851326133112746905
   PubMed Web of Science ®Google Scholar
• LighvaniAAFruchtDMJankovicDT-bet is rapidly induced by interferon gamma in lymphoid and myeloid cellsProc Natl Acad Sci U S A20019826151371514211752460
   PubMed Web of Science ®Google Scholar
• LantelmeEMantovaniSPalermoBCampanelliRSallustoFGiachinoCKinetics of GATA-3 gene expression in early polarizing and committed human T cellsImmunology2001102212313011260316
   PubMed Web of Science ®Google Scholar
• LeeHJTakemotoNKurataHGATA-3 induces T helper cell type 2 (Th2) cytokine expression and chromatin remodeling in committed Th1 cellsJ Exp Med2000192110511510880531
   PubMed Web of Science ®Google Scholar
• ArbuckleMRMcClainMTRubertoneMVDevelopment of autoantibodies before the clinical onset of systemic lupus erythematosusN Engl J Med2003349161526153314561795
   PubMed Web of Science ®Google Scholar
• ThompsonCPowrieFRegulatory T cellsCurr Opin Pharmacol20044440841415251137
   PubMed Web of Science ®Google Scholar
• KammerGMPerlARichardsonBCTsokosGCAbnormal T cell signal transduction in systemic lupus erythematosusArthritis Rheum20024651139115412115215
   PubMed Web of Science ®Google Scholar
• JiangHChessLAn integrated view of suppressor T cell subsets in immunoregulationJ Clin Invest200411491198120815520848
   PubMed Web of Science ®Google Scholar
• NelsonBHIL-2, regulatory T cells, and toleranceJ Immunol200417273983398815034008
   PubMed Web of Science ®Google Scholar
• MalekTRBayerALTolerance, not immunity, crucially depends on IL-2Nat Rev Immunol20044966567415343366
   PubMed Web of Science ®Google Scholar
• LeeJHWangLCLinYTYangYHLinDTChiangBLInverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosusImmunology2006117228028616423064
   PubMed Web of Science ®Google Scholar
• ValenciaXYarboroCIlleiGLipskyPEDeficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosusJ Immunol200717842579258817277168
   PubMed Web of Science ®Google Scholar
• LyssukEYTorgashinaAVSolovievSKNassaonovELBykovskaiaSNReduced number and function of CD4+CD25highFoxP3+ regulatory T cells in patients with systemic lupus erythematosusAdv Exp Med Biol200760111311917712998
   PubMed Web of Science ®Google Scholar
• LinSCChenKHLinCHKuoCCLingQDChanCHThe quantitative analysis of peripheral blood FOXP3-expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patientsEur J Clin Invest2007371298799618036033
   PubMed Web of Science ®Google Scholar
• GaiplUSSheriffAFranzSIneff icient clearance of dying cells and autoreactivityCurr Top Microbiol Immunol200630516117616724805
   PubMed Web of Science ®Google Scholar
• KruseKJankoCUrbonaviciuteVInefficient clearance of dying cells in patients with SLE: anti-dsDNA autoantibodies, MFG-E8, HMGB-1 and other playersApoptosis20101591098111320198437
   PubMed Web of Science ®Google Scholar
• KawaiMKitadeHMathieuCWaerMPirenneJInhibitory and stimulatory effects of cyclosporine A on the development of regulatory T cells in vivoTransplantation20057991073107715880046
   PubMed Web of Science ®Google Scholar
• SchwarzT25 years of UV-induced immunosuppression mediated by T cells-from disregarded T suppressor cells to highly respected regulatory T cellsPhotochem Photobiol2008841101818173696
   PubMed Web of Science ®Google Scholar
• HartPHTownleySLGrimbaldestonMAKhalilZFinlay-JonesJJMast cells, neuropeptides, histamine, and prostaglandins in UVinduced systemic immunosuppressionMethods2002281798912231191
   PubMed Web of Science ®Google Scholar
• ZhangYRamosBFJakschikBAAugmentation of reverse arthus reaction by mast cells in miceJ Clin Invest19918838418461832174
   PubMed Web of Science ®Google Scholar
• DanilewiczMWagrowska-DanilewiczMQuantitative analysis of interstitial mast cells in lupus and non-lupus membranous glomerulopathyPol J Pathol200152421121711915183
   PubMedGoogle Scholar
• EklundKKMast cells in the pathogenesis of rheumatic diseases and as potential targets for anti-rheumatic therapyImmunol Rev2007217385217498050
   PubMed Web of Science ®Google Scholar
• WoolleyDETetlowLCMast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesionArthritis Res200021657411219391
   PubMedGoogle Scholar
• PablosJLSantiagoBGalindoMCarreiraPEBallestinCGomez-ReinoJJKeratinocyte apoptosis and p53 expression in cutaneous lupus and dermatomyositisJ Pathol19991881636810398142
   PubMed Web of Science ®Google Scholar
• ReefmanEde JongMCKuiperHIs disturbed clearance of apoptotic keratinocytes responsible for UVB-induced inflammatory skin lesions in systemic lupus erythematosus?Arthritis Res Ther200686R15617014704
   PubMed Web of Science ®Google Scholar
• OhiraTAritaMOmoriKRecchiutiAvan DykeTESerhanCNResolvin E1 receptor activation signals phosphorylation and phagocytosisJ Biol Chem201028553451346119906641
   PubMed Web of Science ®Google Scholar
• BonventreJVPhospholipase A2 and signal transductionJ Am Soc Nephrol1992321281501391715
   PubMed Web of Science ®Google Scholar
• GodsonCMitchellSHarveyKPetasisNAHoggNBradyHRCutting edge: lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophagesJ Immunol200016441663166710657608
   PubMed Web of Science ®Google Scholar
• GilroyDWColville-NashPRWillisDChiversJPaul-ClarkMJWilloughbyDAInducible cyclooxygenase may have anti-inflammatory propertiesNat Med19995669870110371510
   PubMed Web of Science ®Google Scholar
• GilroyDWNewsonJSawmynadenPWilloughbyDACroxtallJDA novel role for phospholipase A2 isoforms in the checkpoint control of acute inflammationFASEB J200418348949815003994
   PubMed Web of Science ®Google Scholar
• CominelliFNastCCLlerenaRDinarelloCAZipserRDInterleukin 1 suppresses inflammation in rabbit colitis. Mediation by endogenous prostaglandinsJ Clin Invest19908525825862298922
   PubMed Web of Science ®Google Scholar
• SchwabJHAnderleSKBrownRRDalldorfFGThompsonRCPro- and anti-inflammatory roles of interleukin-1 in recurrence of bacterial cell wall-induced arthritis in ratsInfect Immun19915912443644421834576
   PubMed Web of Science ®Google Scholar
• CroxtallJDChoudhuryQTokumotoHFlowerRJLipocortin-1 and the control of arachidonic acid release in cell signalling. Glucocorticoids inhibit G protein-dependent activation of cPLA2 activityBiochem Pharmacol19955044654747646551
   PubMed Web of Science ®Google Scholar
• MunckAGuyrePMHolbrookNJPhysiological functions of glucocorticoids in stress and their relation to pharmacological actionsEndocr Rev19845125446368214
   PubMed Web of Science ®Google Scholar
• WalevIKleinJHusmannMPotassium regulates IL-1 beta processing via calcium-independent phospholipase A2J Immunol2000164105120512410799869
   PubMed Web of Science ®Google Scholar
• WuC-CCroxtallJDPerrettiMLipocortin 1 mediates the inhibition by dexamethasone of the induction by endotoxin of nitric oxide synthase in the ratProc Natl Acad Sci U S A1995928347334777536934
   PubMed Web of Science ®Google Scholar
• LasaMAbrahamSMBoucheronCSaklatvalaJClarkARDexamethasone causes sustained expression of mitogen-activated protein kinase (MAPK) phosphatase 1 and phosphatase-mediated inhibition of MAPK p38Mol Cell Biol200222227802781112391149
   PubMed Web of Science ®Google Scholar
• CraffordLJWilderRLRistimakiAPCyclooxygenase-1 and -2 expression in rheumatoid arthritis synovial tissuesJ Clin Invest1994933109511018132748
   PubMed Web of Science ®Google Scholar
• RadomskiMWPalmerRMMoncadaSGlucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cellsProc Natl Acad Sci U S A1990872410043100471702214
   PubMed Web of Science ®Google Scholar
• HoeckWGRameshaCSChangDJFanNHellerRACytoplasmic phospholipase A2 activity and gene expression are stimulated by tumor necrosis factor: dexamethasone blocks the inducible synthesisProc Natl Acad Sci U S A19939010447544798506288
   PubMed Web of Science ®Google Scholar
• KunickaJETalleMADenhardtGHBrownMPrinceLAGoldsteinGImmunosuppression by glucocorticoids: inhibition of production of multiple lymphokines by in vivo administration of dexamethasoneCell Immunol1993149139498513511
   PubMed Web of Science ®Google Scholar
• CalandraTBernhagenJMetzCNMIF as a glucocorticoid- induced modulator of cytokine productionNature1995377654468717659164
   PubMed Web of Science ®Google Scholar
• SalveminiDSeibertKMasferrerJLMiskoTPCurrieMGNeedlemanPEndogenous nitric oxide enhances prostaglandin production in a model of renal inflammationJ Clin Invest1994935194019477514189
   PubMed Web of Science ®Google Scholar
• ZaitsuMHamasakiYTsujiKDexamethasone accelerates catabolism of leukotriene C4 in bronchial epithelial cellsEur Respir J2003221354212882448
   PubMed Web of Science ®Google Scholar
• DworskiRFitzgeraldGAOatesJAShellerJREffect of oral prednisone on airway inflammatory mediators in atopic asthmaAm J Respir Crit Care Med.19941494 Pt 19539598143061
   PubMed Web of Science ®Google Scholar
• FerranteJVFerranteANovel role of lipoxygenases in the inflammatory response: promotion of TNF mRNA decay by 15-hydroperoxyeicosatetraenoic acid in a monocytic cell lineJ Immunol200517463169317215749845
   PubMed Web of Science ®Google Scholar
• ArielAChiangNAritaMPetasisNASerhanCNAspirin-triggered lipoxin A4 and B4 analogs block extracellular signal-regulated kinase-dependent TNF-alpha secretion from human T cellsJ Immunol2003170126266627212794159
   PubMed Web of Science ®Google Scholar
• WuSHLuCDongLZhouGPHeZGChenZQLipoxin A4 inhibits TNF-alpha-induced production of interleukins and proliferation of rat mesangial cellsKidney Int2005681354615954894
   PubMed Web of Science ®Google Scholar
• HayakawaMIshidaNTakeuchiKArachidonic acid-selective cytosolic phospholipase A2 is crucial in the cytotoxic action of tumor necrosis factorJ Biol Chem19932681511290112957684376
   PubMed Web of Science ®Google Scholar
• DasUNA Perinatal Strategy for Preventing Adult Disease: The Role of Long-chain Polyunsaturated Fatty AcidsBostonKluwer Academic Press2002
   Google Scholar
• HuangYSDrummondRHorrobinDFProtective effect of gamma-linolenic acid on aspirin induced gastric hemorrhage in ratsDigestion198736136413030865
   PubMed Web of Science ®Google Scholar
• ManjariVDasUNEffect of polyunsaturated fatty acids on dexamethasone-induced gastric mucosal damageProstaglandins Leukot Essent Fatty Acids2000622859610780873
   PubMed Web of Science ®Google Scholar
• DasUNEssential fatty acids and their metabolites could function as endogenous HMG-CoA reductase and ACE enzyme inhibitors, antiarrhythmic, anti-hypertensive, anti-atherosclerotic, anti-inflammatory, cytoprotective, and cardioprotective moleculesLipids Health Dis200873718922179
   PubMed Web of Science ®Google Scholar
• DasUNCan essential fatty acids reduce the burden of disease(s)Lipids Health Dis20087918348729
   PubMed Web of Science ®Google Scholar
• DasUNEssential fatty acids – a reviewCurr Pharm Biotechnol20067646748217168664
   PubMed Web of Science ®Google Scholar
• Krishna MohanIDasUNPrevention of chemically induced diabetes mellitus in experimental animals by polyunsaturated fatty acidsNutrition200117212615111240341
   PubMed Web of Science ®Google Scholar
• SureshYDasUNLong-chain polyunsaturated fatty acids and chemically- induced diabetes mellitus: effect of ω-6 fatty acidsNutrition20031929311412591540
   PubMed Web of Science ®Google Scholar
• SureshYDasUNLong-chain polyunsaturated fatty acids and chemically- induced diabetes mellitus: effect of ω-3 fatty acidsNutrition200319321322812620523
   PubMed Web of Science ®Google Scholar
• SureshYDasUNDifferential effect of saturated, monounsaturated, and polyunsaturated fatty acids on alloxan-induced diabetes mellitusProstaglandins Leukot Essent Fatty Acids200674319921316412622
   PubMed Web of Science ®Google Scholar
• DasUNMohanIKRajuTREffect of corticosteroids and eicosapentaenoic acid/docosahexaenoic acid on pro-oxidant and antioxidant status and metabolism of essential fatty acids in patients with glomerular disordersProstaglandins Leukot Essent Fatty Acids200165419720311728172
   PubMed Web of Science ®Google Scholar
• DasUNEssential fatty acids: biochemistry, physiology, and pathologyBiotechnol J20061442043916892270
   PubMedGoogle Scholar
• KambeTMurakamiMKudoIPolyunsaturated fatty acids potentiate interleukin-1-stimulated arachidonic acid release by cells overexpressing type IIA secretory phospholipase A2FEBS Lett19994531–2818410403380
   PubMed Web of Science ®Google Scholar
• DasUNCan perinatal supplementation of long-chain polyunsaturated fatty acids prevent atopy, bronchial asthma and other inflammatory conditions?Med Sci Monit2006126RA9911116733498
   PubMed Web of Science ®Google Scholar
• BelmontHMLevartovskyDGoelAIncreased nitric oxide production accompanied by the up-regulation of inducible nitric oxide synthase in vascular endothelium from patients with systemic lupus erythematosusArthritis Rheum19974010181018169336415
   PubMed Web of Science ®Google Scholar
• WanchuAKhullarMDeodharSDBamberyPSudANitric oxide synthesis is increased in patients with systemic lupus erythematosusRheumatol Int199818241439782531
   PubMed Web of Science ®Google Scholar
• OatesJCChristensenEFReillyCMSelfSEGilkesonGSProspective measure of serum 3-nitrotyrosine levels in systemic lupus erythematosus: correlation with disease activityProc Assoc Am Physicians1999111661162110591091
   PubMedGoogle Scholar
• SvenungssonEAnderssonMBrundinLIncreased levels of proinflammatory cytokines and nitric oxide metabolites in neuropsychiatric lupus erythematosusAnn Rheum Dis200160437237911247868
   PubMed Web of Science ®Google Scholar
• GilkesonGCannonCOatesJReillyCGoldmanDPetriMCorrelation of serum measures of nitric oxide production with lupus disease activityJ Rheumatol19992623183249972965
   PubMed Web of Science ®Google Scholar
• YuCCYangCWWuMSMycophenolate mofetil reduces renal cortical inducible nitric oxide synthase mRNA expression and diminishes glomerulosclerosis in MRL/lpr miceJ Lab Clin Med20011381697711433230
   PubMed Web of Science ®Google Scholar
• ReillyCMOatesJCSudianJCrosbyMBHalushkaPVGilkesonGSProstaglandinJ(2) inhibition of mesangial cell iNOS expressionClin Immunol200198333734511237557
   PubMed Web of Science ®Google Scholar
• LemireJMAdamsJSKermani-ArabVBakkeACSakaiRJordanSC1,25-Dihydroxyvitamin D3 suppresses human T helper/inducer lymphocyte activity in vitroJ Immunol19851345303230353156926
   PubMed Web of Science ®Google Scholar
• PichlerJGerstmayrMSzépfalusiZUrbanekRPeterlikMWillheimM1 alpha,25(OH)2D3 inhibits not only Th1 but also Th2 differentiation in human cord blood T cellsPediatr Res2002521121812084841
   PubMed Web of Science ®Google Scholar
• TangJZhouRLugerDCalcitriol suppresses antiretinal autoimmunity through inhibitory effects on the Th17 effector responseJ Immunol200918284624463219342637
   PubMed Web of Science ®Google Scholar
• HuangLWChangKLChenCJLiuHWArginase levels are increased in patients with rheumatoid arthritisKaohsiung J Med Sci200117735836311593962
   PubMedGoogle Scholar
• BultinkIETeerlinkTHeijstJADijkmansBAVoskuylAERaised plasma levels of asymmetric dimethylarginine are associated with cardiovascular events, disease activity, and organ damage in patients with systemic lupus erythematosusAnn Rheum Dis20056491362136516100343
   PubMed Web of Science ®Google Scholar
• SvenungssonECederholmAJensen-UrstadKFeiGZde FaireUFrostegårdJEndothelial function and markers of endothelial activation in relation to cardiovascular disease in systemic lupus erythematosusScand J Rheumatol200837535235918666029
   PubMed Web of Science ®Google Scholar
• GustafssonJGunnarssonIBörjessonOPredictors of the first cardiovascular event in patients with systemic lupus erythematosus – a prospective cohort studyArthritis Res Ther2009116R18620003285
   PubMed Web of Science ®Google Scholar
• DasUNBeneficial effect of L-arginine in collagen vascular diseases: a role for nitric oxideNutrition1993932772788353373
   PubMed Web of Science ®Google Scholar
• FriesRShariatKvon WilmowskyHBöhmMSildenafil in the treatment of Raynaud’s phenomenon resistant to vasodilatory therapyCirculation2005112192980298516275885
   PubMed Web of Science ®Google Scholar
• YoshizumiMKuniharaHMoritaTInterleukin-1 increases the production of endothelin-1 by cultured endothelial cellsBiochem Biophys Res Commun199016613243292405848
   PubMed Web of Science ®Google Scholar
• LiuJFarmerJDJrLaneWSFriedmanJWeissmanISchreiberSCalcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexesCell19916648078151715244
   PubMed Web of Science ®Google Scholar
• DongGPanaroFBogettiDStandard chronic immunosuppression after kidney transplantation for systemic lupus erythematosus eliminates recurrence of diseaseClin Transplant2005191566015659135
   PubMed Web of Science ®Google Scholar
• TanakaHOkiETsurugaKYashiroTHanadaIItoEManagement of young patients with lupus nephritis using tacrolimus administered as a single daily doseClin Nephrol200972643043619954719
   PubMed Web of Science ®Google Scholar
• YoonKHEfficacy and cytokine modulating effects of tacrolimus in systemic lupus erythematosus: a reviewJ Biomed Biotechnol2010201068648020625508
   PubMedGoogle Scholar
• Pego-ReigosaJMIsenbergDASystemic lupus erythematosus: pharmacological developments and recommendations for a therapeutic strategyExpert Opin Investig Drugs20081713141
   PubMed Web of Science ®Google Scholar
• EdwardsJCSzczepanskiLSzechinskiJEfficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritisN Engl J Med2004350252572258115201414
   PubMed Web of Science ®Google Scholar
• SabahiRAnolikJHB-cell-targeted therapy for systemic lupus erythematosusDrugs200666151933194817100405
   PubMed Web of Science ®Google Scholar
• DingCFooteSJonesGB-cell-targeted therapy for systemic lupus erythematosus: an updateBioDrugs200822423924918611066
   PubMed Web of Science ®Google Scholar
• HicksPSSaunero-NavaLDu ClosTWMoldCSerum amyloid P component binds to histones and activates the classical complement pathwayJ Immunol199214911368936941431140
   PubMed Web of Science ®Google Scholar
• BickerstaffMCBottoMHutchinsonWLSerum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunityNat Med19995669469710371509
   PubMed Web of Science ®Google Scholar
• GillmoreJDHutchinsonWLHerbertJAutoimmunity and glomerulonephritis in mice with targeted deletion of the serum amyloid P component gene: SAP deficiency or strain combinationImmunology200411225526415147569
   PubMed Web of Science ®Google Scholar
• BraunASisJMaxRAnti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseasesScand J Rheumatol200736429129817763207
   PubMed Web of Science ®Google Scholar
• SomaMTamaokiTKawanoHMice lacking serum amyloid P component do not necessarily develop severe autoimmune diseaseBiochem Biophys Res Commun2001286120020511485329
   PubMed Web of Science ®Google Scholar
• TsukamotoHHoriuchiTClinical aspects of the complement systemRinsho Byori200654775776216913667
   PubMedGoogle Scholar
• ChenMDahaMRKallenbergCGThe complement system in systemic autoimmune diseaseJ Autoimmun2010343J27628620005073
   PubMed Web of Science ®Google Scholar
• BraudeIAHochbergMCArnettFCWaldmannTAIn vitro suppression of anti-DNA antibody and immunoglobulin synthesis in systemic lupus erythematosus patients by human gamma interferonJ Rheumatol19881534384443132556
   PubMed Web of Science ®Google Scholar
• NicolettiFMeroniPdi MarcoRIn vivo treatment with a monoclonal antibody to interferon-gamma neither affects the survival nor the incidence of lupus-nephritis in the MRL/lpr-lpr mouseImmunopharmacology199224111161452442
   PubMed Web of Science ®Google Scholar
• RönnblomLPascualVThe innate immune system in SLE: type I interferons and dendritic cellsLupus200817539439918490415
   PubMed Web of Science ®Google Scholar
• SatomiNSakuraiAHaranakaKRelationship of hypoglycemia to tumor necrosis factor production and antitumor activity: role of glucose, insulin, and macrophagesJ Natl Cancer Inst1985746125512603889459
   PubMedGoogle Scholar
• FrakerDLMerinoMJNortonJAReversal of the toxic effects of cachectin by concurrent insulin administrationAm J Physiol.19892566 Pt 1E7257312660586
   PubMed Web of Science ®Google Scholar
• OttleczAKoltaiMBlazsoGMinkerEContribution to the regulatory role of insulin in inflammation and anaphylaxisInt Arch Allergy Appl Immunol1978563284286621117
   PubMedGoogle Scholar
• OttleczAKoltaiMGecseAFurther studies on the antiinflammatory effect of insulinAgents Actions19777487491930760
   PubMedGoogle Scholar
• OttleczAGecseAKoltaiMWestGBInvolvement of the kinin system in the insulin-induced inhibition of carrageenin oedema in ratsMonogr Allergy197712131137917016
   PubMedGoogle Scholar
• BoichotESannomiyaPEscofierNEndotoxin-induced acute lung injury in rats. Role of insulinPulm Pharmacol Ther199912528529010545284
   PubMed Web of Science ®Google Scholar
• DasUNIs insulin an antiinflammatory molecule?Nutrition200117540941311377135
   PubMed Web of Science ®Google Scholar
• KubokiKJiangZYTakaharaNRegulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo: a specific vascular action of insulinCirculation2000101667668110673261
   PubMed Web of Science ®Google Scholar
• KojdaGHarrisonDInteraction between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failureCardiovasc Res199943356257110690328
   PubMed Web of Science ®Google Scholar
• SakaueSNishihiraJHirokawaJRegulation of macrophage migration inhibitory factor (MIF) expression by glucose and insulin in adipocytes in vitroMol Med19995636137110415161
   PubMed Web of Science ®Google Scholar
• WaeberGCalandraTRoduitRInsulin secretion is regulated by the glucose-dependent production of islet beta cell macrophage migration inhibitory factorProc Natl Acad Sci U S A1997949478247879114069
   PubMed Web of Science ®Google Scholar
• HirokawaJSakaueSFuruyaYTumor necrosis factor alpha regulates the gene expression of macrophage migration inhibitory factor through tyrosine kinase-dependent pathway in 3T3-L1 adipocytesJ Biochem (Tokyo)199812347337399538268
   PubMed Web of Science ®Google Scholar
• HotamisligilGSThe role of TNFalpha and TNF receptors in obesity and insulin resistanceJ Intern Med1999245662162510395191
   PubMed Web of Science ®Google Scholar
• DasUNPossible beneficial action(s) of glucose-insulin-potassium regimen in acute myocardial infarction and inflammatory conditions: a hypothesisDiabetologia20004381081108210990092
   PubMed Web of Science ®Google Scholar
• DasUNCan glucose-insulin-potassium regimen suppress inflammatory bowel disease?Med Hypotheses200157218318511461170
   PubMed Web of Science ®Google Scholar
• DasUNHypothesis: can glucose-insulin-potassium regimen in combination with polyunsaturated fatty acids suppress lupus and other inflammatory diseases?Prostaglandins Leukot Essent Fatty Acids200165210911311545628
   PubMed Web of Science ®Google Scholar
• LiJZhangHWuFInsulin inhibits tumor necrosis factor- α-induction in myocardial ischemia/reperfusion: role of Akt and endothelial nitric oxide synthase phosphorylationCrit Care Med20083651551155818434880
   PubMed Web of Science ®Google Scholar
• ReadeMCFinkMPBench-to-bedside review: amelioration of acute renal impairment using ethyl pyruvateCrit Care20059655656016356237
   PubMed Web of Science ®Google Scholar
• SimsCAWattanasirichaigoonSMenconiMJAjamiAMFinkMPRinger’s ethyl pyruvate solution ameliorates ischemia/reperfusion-induced intestinal mucosal injury in ratsCrit Care Med20012981513151811505117
   PubMed Web of Science ®Google Scholar
• TawadrousZSDeludeRLFinkMPResuscitation from hemorrhagic shock with Ringer’s ethyl pyruvate solution improves survival and ameliorates intestinal mucosal hyperpermeability in ratsShock200217647347712069183
   PubMed Web of Science ®Google Scholar
• DobsakPCourderot-MasuyerCZellerMAntioxidative properties of pyruvate and protection of the ischemic rat heart during cardioplegiaJ Cardiovasc Pharmacol199934565165910547080
   PubMed Web of Science ®Google Scholar
• CicaleseLLeeKSchrautWWatkinsSBorleAStankoRPyruvate prevents ischemia-reperfusion mucosal injury of rat small intestineAm J Surg19961711971008554159
   PubMed Web of Science ®Google Scholar
• VenkataramanRKellumJASongMFinkMPResuscitation with Ringer‘s ethyl pyruvate solution prolongs survival and modulates plasma cytokine and nitrite/nitrate concentrations in a rat model of lipopolysaccharide-induced shockShock200218650751212462557
   PubMed Web of Science ®Google Scholar
• DasUNPyruvate is an endogenous anti-inflammatory and anti-oxidant moleculeMed Sci Monit2006125RA798416641887
   PubMed Web of Science ®Google Scholar
• DasUNIs pyruvate an endogenous anti-inflammatory molecule?Nutrition200622996597216814517
   PubMed Web of Science ®Google Scholar
• DasUNEthyl pyruvate in sepsisAdv Sepsis200761015
   Google Scholar
• BelayevLMarcheselliVLKhoutorovaLDocosahexaenoic acid complexed to albumin elicits high-grade ischemic neuroprotectionStroke200536111812315569878
   PubMed Web of Science ®Google Scholar
• DasUNAlbumin infusion therapy in stroke, sepsis and the critically illCurr Nutr Food Sci20084217226
   Google Scholar
• BorovikovaLVIvanovaSZhangMVagus nerve stimulation attenuates the systemic inflammatory response to endotoxinNature2000405678545846210839541
   PubMed Web of Science ®Google Scholar
• WangHYuMOchaniMNicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammationNature2003421692138438812508119
   PubMed Web of Science ®Google Scholar
• KarimiKBienenstockJWangLForsythePThe vagus nerve modulates CD4+ T cell activityBrain Behav Immun201024231632319887104
   PubMed Web of Science ®Google Scholar
• WestmanMEngströmMCatrinaAILampaJCell specific synovial expression of nicotinic alpha 7 acetylcholine receptor in rheumatoid arthritis and psoriatic arthritisScand J Immunol200970213614019630919
   PubMed Web of Science ®Google Scholar
• BruchfeldAGoldsteinRSChavanSWhole blood cytokine attenuation by cholinergic agonists ex vivo and relationship to vagus nerve activity in rheumatoid arthritisJ Intern Med201026819410120337855
   PubMed Web of Science ®Google Scholar
• van MaanenMAStoofSPLarosaGJVervoordeldonkMJTakPPRole of the cholinergic nervous system in rheumatoid arthritis: aggravation of arthritis in nicotinic acetylcholine receptor alpha7 subunit gene knockout miceAnn Rheum Dis20106991717172320511609
   PubMed Web of Science ®Google Scholar
• JobstBCElectrical stimulation in epilepsy: vagus nerve and brain stimulationCurr Treat Options Neurol201012544345320842599
   PubMed Web of Science ®Google Scholar
• LiWGGavrilaDLiuXGhrelin inhibits proinflammatory responses and nuclear factor-kappaB activation in human endothelial cellsCirculation2004109182221222615117840
   PubMed Web of Science ®Google Scholar
• WuRDongWCuiXGhrelin down-regulates proinflammatory cytokines in sepsis through activation of the vagus nerveAnn Surg2007245348048617435556
   PubMed Web of Science ®Google Scholar
• WuRZhouMDasPGhrelin inhibits sympathetic nervous activity in sepsisAm J Physiol Endocrinol Metab20072936E1697170217911350
   PubMed Web of Science ®Google Scholar
• ChornyAAndersonPGonzalez-ReyEDelgadoMGhrelin protects against experimental sepsis by inhibiting high-mobility group box 1 release and by killing bacteriaJ Immunol2008180128369837718523304
   PubMed Web of Science ®Google Scholar
• WuRDongWZhouMGhrelin attenuates sepsis-induced acute lung injury and mortality in ratsAm J Respir Crit Care Med2007176880581317626913
   PubMed Web of Science ®Google Scholar
• ChangLZhaoJYangJZhangZDuJTangCTherapeutic effects of ghrelin on endotoxic shock in ratsEur J Pharmacol20034732–317117612892835
   PubMed Web of Science ®Google Scholar